课题基金 / 基金详情

IL-2-anti-IL-2 complexes in immunity to blood stage malaria infection and prevention of cerebral immunopathology

IL-2-anti-IL-2 complexes in immunity to blood stage malaria infection and prevention of cerebral immunopathology
IL-2-抗IL-2复合物对血期疟疾感染的免疫和脑免疫病理学的预防
批准号:
nhmrc : 613702
负责人:
A/Pr Ashraful Haque
金额:
$39.1万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2010
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2010-01-01 至 2012-12-31

项目摘要

项目成果

A/Pr Ashraful Haque的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cerebral malaria is a severe complication of malaria infection, which accounts for a large proportion of malaria-related deaths each year. There is no vaccine against malaria licensed for use in humans. Trial vaccines have been shown to protect poorly against cerebral malaria, and have on occasion, increased the its incidence amongst experimental animals. We aim to develop a safe malaria vaccine that controls malaria parasite numbers in the body, and also prevents cerebral malaria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cytokine responses within the GI tract dictate T cell fate and transplant outcome
Cytokine responses within the GI tract dictate T cell fate and transplant outcome
  • 批准号:
    nhmrc : GNT1146859
  • 项目类别:
    Project Grants
  • 资助金额:
    $145.92万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Ashraful Haque
  • 依托单位:
Using single-cell genomics to resolve functional diversification by CD4+ T cells in vivo
Using single-cell genomics to resolve functional diversification by CD4+ T cells in vivo
  • 批准号:
    nhmrc : GNT1126399
  • 项目类别:
    Project Grants
  • 资助金额:
    $104.81万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Ashraful Haque
  • 依托单位:
国内基金
海外基金
基于spA-Gel负载Anti-HMGB1原位靶向免疫耐受的猪胰岛类器官移植研
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    程瑶
  • 依托单位:
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
  • 批准号:
    JCZRQN202500319
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    仇凤启
  • 依托单位:
构建α-突触核蛋白特异性CAR-Treg治疗抗NMDAR脑炎的研究